Shares of Nemus Bioscience Inc (OTCMKTS:NMUS – Get Free Report) crossed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $10.66 and traded as low as $0.60. Nemus Bioscience shares last traded at $0.65, with a volume of 1,004,500 shares.
Nemus Bioscience Price Performance
The firm has a 50-day moving average of $10.66 and a 200 day moving average of $5.37.
About Nemus Bioscience
Nemus Bioscience, Inc, a biopharmaceutical company, focuses on the discovery, development, and commercialization of cannabinoid-based therapeutics. The company's product candidates in preclinical stage include NB1111 for the treatment of glaucoma; NB1222 used for treating chemotherapy induced nausea and vomiting; and NB3111 for the treatment of methicillin-resistant staphylococcus aureus.
Recommended Stories
- Five stocks we like better than Nemus Bioscience
- High Dividend REITs: Are They an Ideal Way to Diversify?
- It’s Time to Buy Into the Super Micro Computer Stock Implosion
- Manufacturing Stocks Investing
- Merger or Not, Albertson’s Companies is a Good Buy
- 10 Best Airline Stocks to Buy
- 3 Cheap Stocks That Shouldn’t Be So
Receive News & Ratings for Nemus Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nemus Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
